Galdes Alphonse 4
4 · BIOGEN INC. · Filed Feb 22, 2021
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Galdes Alphonse
EVP Pharmaceutical Oper & Tech
Transactions
- Award
Restricted Stock Unit
2021-02-18+10,870→ 10,870 totalExercise: $0.00Exp: 2024-02-18→ Common Stock (10,870 underlying)
Footnotes (1)
- [F1]The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date]).